This study evaluates the effects of the Survivorship Wellness Group Program following active treatment, as well as to learn from Survivorship Wellness participants about their concerns regarding the current COVID-19 pandemic. This study may help to evaluate the impact of the survivorship program on patient well-being, provide evidence for use in grant application and publications, and ultimately inform the continued improvement of survivorship care.
PRIMARY OBJECTIVES:
1. To examine the feasibility and acceptability of implementing an interdisciplinary
goal-setting clinical group program focused on domains of physical, psychological, and
spiritual wellness for survivors of cancer at University of California San Francisco
(UCSF).
2. To determine preliminary efficacy of the Survivorship Wellness intervention in regards
to:
1. Increasing knowledge of and perceived confidence in execution of health behavior
changes in domains of physical, emotional, and spiritual wellness for survivors of
cancer.
2. Increasing quality of life.
3. Reducing symptoms of depression and anxiety.
4. Increasing physical activity.
3. To assess differences in patient wellbeing and in the impact of the Survivorship
Wellness program during the period of COVID-19 and telehealth classes.
OUTLINE:
Patients complete surveys over 5-10 minutes at baseline (i.e. before participating in the
program), and at 9 and 15 weeks follow up on the impact of COVID-19 on survivorship. Patients
also complete a survey assessing how patients rate telehealth classes in the Survivorship
Wellness program.
Other: Survey Administration
Participants will complete study specific survey
Inclusion Criteria:
- English-speaking
- Treated for any kind of cancer at UCSF, though finished with active treatments
(defined as chemotherapy, radiation, or surgery) at time of enrollment, and without
evidence of current active cancer
- Sufficient cognitive ability to participate in group activities as determined by their
attending medical oncologist or surgeon
Exclusion Criteria:
- Non-English speaking
- Primary cancer treatment outside of UCSF
- Currently receiving non-maintenance therapies (chemotherapy or radiation) for active
cancer
- Psychiatric illness that would affect the ability to participate in a group activity
University of California, San Francisco
San Francisco, California, United States
Margaret Chesney, MD, Principal Investigator
University of California, San Francisco